Press Release

For immediate release:

Nominated by Shepherd's Hope, an organization that provides free medical care to the uninsured through the efforts of more than 2,500 dedicated volunteers, Triad Isotopes, Inc. is being been recognized by the Central Florida Chapter of the Association of Fundraising Professionals.

Please click on the link below to view the full press release:

http://shepherdshope.org/triad-isotopes-honored-for-philanthropy/

Media Alert:

RE: Triad Isotopes, Inc. not Affiliated with Triad Group, Inc. FDA Press Release

Orlando, Florida, April 8, 2011- Triad Isotopes, Inc. is not affiliated in any manner with Triad Group, Inc. and      H & P Industries. In recent months, Triad Group, Inc. and H & P Industries have been under FDA scrutiny following several voluntary recalls of products, including alcohol pads and sterile lubricating jelly, which were sold by multiple distributors.

Contact: Tikisha Hughes
Triad Isotopes, Inc.
Direct: 407-455-6746
Fax: 407-455-6732
thughes@triadisotopes.com
 
For Immediate Release:
Triad Isotopes Closes Acquisition of Covidien’s U.S. Network of Mallinckrodt Radiopharmacies
 
Orlando, Florida.  June 1, 2010 – Triad Isotopes, Inc., headquartered in Orlando, Florida, announced

Triad is pleased to announce that the Centers for Medicaid and Medicaid Services (CMS) has released a final decision memo for F-18 Sodium Fluoride ( NaF) to identify bone metastasis of cancer. CMS will cover F-18 NaF PET Bone Imaging through Coverage with Evidence Development. The memo can be found using the following link:

http://www.cms.hhs.gov/mcd/viewdecisionmemo.asp?from2=viewdecisionmemo.asp&id=233&

For Immediate Release:
Contact: Michael Griffiths
Triad Isotopes, Inc.
Direct: 407-455-6709
Fax: 407-455-6732
mgriffiths@triadisotopes.com
www.triadisotopes.com

The Institute of Clinical Learning is publishing a Clinical Information Bulletin addressing Characteristics of Attenuation Artifacts.

Orlando Florida, March 12, 2008 – Triad Isotopes, Inc. headquartered in Orlando Florida today announced the timely release of its Institute of Clinical Learning’s Third Clinical Information Bulletin, Characteristics of Attenuation Artifacts.

Triad Isotopes continues to grow its national footprint adding five new locations in South Carolina and Texas.

ORLANDO, Florida, November 8, 2007 - Triad Isotopes, Inc. headquartered in Orlando, Florida announced the acquisition of four radiopharmaceutical companies that operate four nuclear pharmacies in South Carolina and Texas and one cyclotron in South Carolina.

Triad Isotopes attracts industry thought leaders to new group dedicated to academic based research, publishing and training

Triad Isotopes continues to grow its national footprint with the acquisition of the Birmingham Nuclear Pharmacy, Inc.